Patient
SITE009-0036
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE009 (AUS) (Dr. Novak)
consented 2025-10-17
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-27 (study day 315); relationship: NOT RELATED
Grade 2 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-12-11 (study day 237); relationship: not assessed
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-05-13 (study day 25); relationship: NOT RELATED
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-04-27 (study day 9); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.